RadNet (RDNT) Competitors $70.31 -1.45 (-2.02%) Closing price 04:00 PM EasternExtended Trading$69.75 -0.56 (-0.80%) As of 05:05 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock RDNT vs. HIMS, GH, OPCH, SHC, BTSG, WGS, CON, SGRY, PRVA, and HTFLShould you be buying RadNet stock or one of its competitors? The main competitors of RadNet include Hims & Hers Health (HIMS), Guardant Health (GH), Option Care Health (OPCH), Sotera Health (SHC), BrightSpring Health Services (BTSG), GeneDx (WGS), Concentra Group Holdings Parent (CON), Surgery Partners (SGRY), Privia Health Group (PRVA), and Heartflow (HTFL). These companies are all part of the "healthcare" industry. RadNet vs. Its Competitors Hims & Hers Health Guardant Health Option Care Health Sotera Health BrightSpring Health Services GeneDx Concentra Group Holdings Parent Surgery Partners Privia Health Group Heartflow Hims & Hers Health (NYSE:HIMS) and RadNet (NASDAQ:RDNT) are both mid-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their profitability, dividends, risk, earnings, analyst recommendations, valuation, media sentiment and institutional ownership. Do analysts recommend HIMS or RDNT? Hims & Hers Health currently has a consensus target price of $38.92, indicating a potential downside of 6.51%. RadNet has a consensus target price of $71.60, indicating a potential upside of 1.83%. Given RadNet's stronger consensus rating and higher possible upside, analysts plainly believe RadNet is more favorable than Hims & Hers Health.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Hims & Hers Health 3 Sell rating(s) 8 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 1.92RadNet 0 Sell rating(s) 1 Hold rating(s) 4 Buy rating(s) 3 Strong Buy rating(s) 3.25 Which has better valuation & earnings, HIMS or RDNT? Hims & Hers Health has higher earnings, but lower revenue than RadNet. RadNet is trading at a lower price-to-earnings ratio than Hims & Hers Health, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioHims & Hers Health$1.48B6.37$126.04M$0.8052.03RadNet$1.91B2.83$2.79M-$0.20-351.55 Is HIMS or RDNT more profitable? Hims & Hers Health has a net margin of 9.63% compared to RadNet's net margin of -0.78%. Hims & Hers Health's return on equity of 26.26% beat RadNet's return on equity.Company Net Margins Return on Equity Return on Assets Hims & Hers Health9.63% 26.26% 13.06% RadNet -0.78%2.41%0.82% Which has more risk & volatility, HIMS or RDNT? Hims & Hers Health has a beta of 2.14, meaning that its stock price is 114% more volatile than the S&P 500. Comparatively, RadNet has a beta of 1.54, meaning that its stock price is 54% more volatile than the S&P 500. Does the media refer more to HIMS or RDNT? In the previous week, Hims & Hers Health had 10 more articles in the media than RadNet. MarketBeat recorded 24 mentions for Hims & Hers Health and 14 mentions for RadNet. RadNet's average media sentiment score of 1.33 beat Hims & Hers Health's score of 0.81 indicating that RadNet is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Hims & Hers Health 16 Very Positive mention(s) 3 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive RadNet 12 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do insiders & institutionals hold more shares of HIMS or RDNT? 63.5% of Hims & Hers Health shares are held by institutional investors. Comparatively, 77.9% of RadNet shares are held by institutional investors. 17.7% of Hims & Hers Health shares are held by insiders. Comparatively, 5.6% of RadNet shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term. SummaryHims & Hers Health beats RadNet on 10 of the 17 factors compared between the two stocks. Get RadNet News Delivered to You Automatically Sign up to receive the latest news and ratings for RDNT and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding RDNT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart RDNT vs. The Competition Export to ExcelMetricRadNetMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$5.41B$4.11B$5.69B$9.68BDividend YieldN/A1.26%6.66%4.54%P/E Ratio-351.5329.1082.6526.40Price / Sales2.83177.81529.10204.59Price / Cash20.6027.1625.7028.92Price / Book4.594.5711.246.06Net Income$2.79M$189.47M$3.28B$266.05M7 Day Performance-0.37%0.68%0.15%-0.07%1 Month Performance28.56%20.02%8.36%5.83%1 Year Performance6.06%14.52%54.25%17.89% RadNet Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)RDNTRadNet3.4918 of 5 stars$70.31-2.0%$71.60+1.8%+8.3%$5.41B$1.91B-351.5311,021Positive NewsHIMSHims & Hers Health3.0637 of 5 stars$42.36-4.0%$38.92-8.1%+187.6%$9.57B$2.01B52.951,637Gap DownGHGuardant Health3.6658 of 5 stars$67.42+4.6%$57.50-14.7%+163.6%$8.41B$828.85M-20.132,021Positive NewsGap DownOPCHOption Care Health4.93 of 5 stars$28.68-0.2%$35.75+24.7%-10.4%$4.65B$5.37B22.948,088News CoveragePositive NewsSHCSotera Health2.1718 of 5 stars$16.37+1.0%$16.00-2.3%+6.0%$4.65B$1.12B204.653,000Positive NewsBTSGBrightSpring Health Services1.6499 of 5 stars$23.69-0.2%$25.67+8.3%+88.8%$4.20B$11.27B76.4235,000Positive NewsWGSGeneDx1.7326 of 5 stars$129.49+0.4%$101.63-21.5%+305.4%$3.72B$305.45M2,589.801,200Gap DownCONConcentra Group Holdings Parent2.2804 of 5 stars$23.78+0.2%$27.50+15.7%-2.8%$3.05B$1.90B19.9811,250News CoveragePositive NewsSGRYSurgery Partners3.2668 of 5 stars$22.69-0.1%$33.00+45.4%-29.0%$2.91B$3.11B-15.8712,200Positive NewsPRVAPrivia Health Group3.8023 of 5 stars$23.04+5.6%$28.08+21.9%+14.4%$2.83B$1.74B209.47810Analyst RevisionHTFLHeartflowN/A$31.50-2.0%N/AN/A$2.56BN/A0.00699News CoverageAnalyst Forecast Related Companies and Tools Related Companies Hims & Hers Health Alternatives Guardant Health Alternatives Option Care Health Alternatives Sotera Health Alternatives BrightSpring Health Services Alternatives GeneDx Alternatives Concentra Group Holdings Parent Alternatives Surgery Partners Alternatives Privia Health Group Alternatives Heartflow Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:RDNT) was last updated on 9/2/2025 by MarketBeat.com Staff From Our PartnersMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredThe day and month stocks are most likely to crash nextGood News for Stocks 50-year Wall Street veteran, Marc Chaikin is stepping forward to share why history giv...Chaikin Analytics | SponsoredLeaked Gov’t Memo Reveals $100 Trillion DeadlineOnly Days Left to Claim Your Share of Trump's $100T Play Trump's economic blueprint is about to go live, an...Stansberry Research | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | Sponsored2013 Bitcoin miner reveals his trading system (free)While everyone else is gambling on meme coins or chasing the next "100x moonshot," our members are systematica...Crypto Swap Profits | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored6-Figure Target for BTC by 2025Crypto ETF records broken – here's what’s next The biggest names in finance have built the infrastructure f...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding RadNet, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share RadNet With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free RDNT Stock Alerts